UDI Compliance for Medical Device Labels

UDI Compliance for Medical Device Labels

FDA UDI Requirements and Practical Guidance for Manufacturers
The Unique Device Identification (UDI) system is a cornerstone of FDA medical device regulation, designed to uniquely identify each device throughout its lifecycle. By improving traceability, enabling faster recalls, supporting adverse event reporting, and integrating with electronic health records and supply chains, UDIs enhance patient safety and operational efficiency.


For manufacturers, quality teams, and regulatory professionals, understanding UDI compliance is critical not only for regulatory alignment but also for maintaining inspection-ready processes and embedding traceability into the Quality Management System (QMS).

What Is a Unique Device Identifier (UDI)?

A Unique Device Identifier (UDI) is a standardized code assigned to medical devices to allow precise identification throughout the device lifecycle. It consists of two main components:


  • The Device Identifier (DI), which is fixed and identifies the device model, version, and manufacturer.

  • The Production Identifier (PI), which provides variable information such as lot or batch numbers, serial numbers, manufacturing dates, or expiration dates.

Together, the DI and PI ensure that every device can be tracked from production through distribution, use, and disposal. UDIs form the foundation for traceability, recall management, and regulatory compliance, while supporting operational and supply chain efficiency.

Regulatory Framework for UDI Compliance

UDI requirements are established under 21 CFR Part 801 and 21 CFR Part 830, which collectively define how devices must be identified, labeled, and reported to the FDA. Part 801 specifies labeling obligations including placement, format, and content, while Part 830 defines UDI assignment, direct device marking, and submission to the Global Unique Device Identification Database (GUDID).


Compliance also intersects with 21 CFR Part 820, the Quality System Regulation, which governs label controls, documentation, and recordkeeping. Together, these regulations create a comprehensive framework ensuring that medical devices are uniquely identifiable, traceable, and fully documented throughout their lifecycle.


Labeling Requirements for UDI Compliance

All devices intended for individual distribution must carry a UDI on their label and packaging. For reusable or sterilized devices, direct marking on the device itself is often required to maintain identification through repeated use.


Labels must include both human-readable formats, for visual interpretation by personnel and inspectors, and machine-readable formats, such as barcodes or data matrix symbols, to enable electronic scanning for inventory management, electronic health records, and regulatory oversight. Presenting both formats ensures that devices are traceable, identifiable, and inspection-ready.

Where UDI Must Appear

The UDI must appear on all device labels, each packaging level intended for distribution, and, when applicable, directly on the device. Placement must balance visibility, readability, and scannability while accounting for sterilization, handling, and environmental exposure. Proper placement ensures that devices can be rapidly identified in clinical, supply chain, and regulatory contexts.

Human‑Readable and Machine‑Readable Formats

UDIs are required in two complementary formats. The human-readable portion allows staff and inspectors to read the Device and Production Identifiers directly, while the machine-readable portion, typically in barcode or data matrix form, allows for automated scanning. Machine-readable codes must be validated for durability and scannability under expected use conditions, including sterilization, cleaning, and routine handling. Together, these formats create a reliable identification system across clinical, regulatory, and operational workflows.

Production Identifiers (PI)

Production Identifiers provide variable information essential for traceability. This may include lot or batch numbers, serial numbers, and manufacturing or expiration dates. Integrating PIs into labeling ensures that each unit can be uniquely tracked, supporting recalls, adverse event investigations, and post-market surveillance. Within a Quality Management System, PIs should be reconciled with production data, linked to device history records, and maintained in controlled documentation to demonstrate regulatory compliance.

Compliance Dates and Enforcement Considerations

The FDA implemented UDI compliance in phased deadlines based on device risk class: Class III devices in 2014, implantable and life-supporting devices in 2015, most Class II devices in 2016, and certain Class I and unclassified devices through 2018.


As of 2026, all marketed devices must comply with UDI regulations. Manufacturers are now focused on maintaining ongoing compliance, including updates to GUDID submissions for new device versions, modifications to labels, and routine reconciliation of records. Continuous monitoring, documentation, and integration into quality systems are essential to ensure inspection readiness and reduce regulatory risk.

Submitting to the Global Unique Device Identification Database (GUDID)

The Device Identifier portion of the UDI must be submitted to GUDID, the FDA’s public repository of device identification information. GUDID standardizes device data, allowing healthcare providers, regulators, and supply chains to track and access device information reliably. Submissions include the brand, model, version, and issuing agency, while Production Identifiers are maintained internally for traceability. Accurate GUDID submissions are essential for regulatory compliance and operational integrity.

Exceptions and Alternatives to UDI Requirements

Some devices may qualify for exceptions or alternative labeling approaches when standard UDI placement is impractical, such as devices with extremely small surfaces or unique configurations. Manufacturers must document the rationale, perform a risk assessment, and outline mitigation strategies to ensure that identification and traceability remain equivalent to standard UDI requirements. Understanding these options helps manufacturers maintain compliance without compromising safety or traceability.

Operationalizing UDI Compliance Within Quality Systems

UDI compliance is most effective when embedded into the Quality Management System. This includes integrating UDI assignment, label approval, barcode validation, reconciliation, and recordkeeping into routine operations. By making UDI compliance part of everyday processes, manufacturers can maintain consistent traceability, meet regulatory expectations, and stay inspection-ready.

Label Design and Approval Procedures

Label design should follow structured review and approval processes. Regulatory, quality, and operations teams should collaborate to confirm that UDIs are correctly formatted, legible, and properly positioned. Controlled document management ensures that label specifications are maintained, and any revisions are documented and approved systematically. This process reduces errors and reinforces compliance.

Barcode Validation and Durability Testing

Machine-readable UDIs must be validated to ensure consistent scannability throughout the device lifecycle. Barcodes or data matrix codes should withstand sterilization, handling, and environmental exposure while remaining legible. Validation against recognized standards from issuing agencies ensures that scanning systems and regulators can reliably interpret the codes, supporting operational reliability and inspection readiness.

Traceability, Reconciliation, and Recordkeeping

Effective traceability links each UDI to its production and device history records, ensuring accountability from manufacture through distribution and use. Labels must be reconciled with production logs, distribution records, and, for reusable devices, reprocessing documentation. Maintaining records in a controlled and organized system provides transparency, supports audits, and allows rapid action in the event of recalls or adverse events. Embedding traceability into quality operations ensures that devices remain fully trackable and compliant.

Common UDI Compliance Challenges

Even with clear regulations, manufacturers face challenges such as selecting the correct issuing agency, formatting Device and Production Identifiers correctly, ensuring barcode durability, submitting accurate data to GUDID, and integrating UDI processes into legacy quality systems. Addressing these challenges requires deliberate process design, collaboration across regulatory, quality, and operational teams, and ongoing monitoring to maintain consistent compliance.

Best Practices for UDI Compliance

Maintaining UDI compliance requires embedding best practices throughout the labeling lifecycle. Labels should be reviewed and approved through structured workflows, barcodes validated for durability and readability, and labels reconciled with production records. Controlled change management ensures updates are consistently applied, and periodic internal audits confirm processes remain effective. Following these practices sustains inspection readiness, minimizes regulatory risk, and supports traceable, reliable labeling that protects patient safety.

How UDI Fits Within the Broader FDA Labeling Landscape

UDI compliance complements broader FDA labeling regulations. While UDI ensures unique identification and traceability, 21 CFR Part 801 governs label content, warnings, and intended use statements, and 21 CFR Part 820 ensures label controls are embedded in the quality system. Integrating UDI within this broader framework provides a cohesive labeling strategy that aligns identification, content accuracy, and operational control, ensuring full regulatory compliance.


How GMP Labeling Supports FDA-Compliant Medical Device Labeling

At GMP Labeling, we provide solutions that integrate UDI compliance directly into operational workflows. This includes regulatory-aware label design, durable and compliant printing, barcode validation, and alignment with quality systems. 


By embedding compliance into daily operations, GMP Labeling reduces regulatory risk, supports inspection readiness, and ensures labels remain accurate, traceable, and durable throughout the device lifecycle. Manufacturers can focus on delivering safe, compliant medical devices with confidence in their labeling processes.

FDA Medical Device Labeling Requirements FAQs

Even experienced manufacturers have questions about FDA medical device labeling requirements. For answers to common questions, explore our comprehensive Medical Device Labeling FAQ Page for detailed guidance on staying compliant with FDA labeling regulations.

Related Products

Medical Device Labels
Ensure every device meets FDA labeling requirements with high-quality, durable labels designed for regulatory compliance. Our solutions support inspection readiness and traceability from production to distribution.

Custom Labels for Medical Devices

Get labels tailored to your device’s specifications, including size, material, and adhesion properties. Custom labels help manufacturers meet regulatory, operational, and environmental demands without compromising compliance.

UDI Compliant Solutions

Simplify compliance with FDA Unique Device Identification (UDI) requirements. Our solutions include barcode-ready designs, direct marking options, and integration with regulatory databases for complete traceability.

!